Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash from Investing Activities (2020 - 2021)

Historic Cash from Investing Activities for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$50.1 million.

  • Design Therapeutics' Cash from Investing Activities fell 260545.55% to -$50.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$53.6 million, marking a year-over-year decrease of 5984.03%. This contributed to the annual value of $44.0 million for FY2024, which is 1633.36% down from last year.
  • According to the latest figures from Q4 2021, Design Therapeutics' Cash from Investing Activities is -$50.1 million, which was down 260545.55% from -$5.0 million recorded in Q3 2021.
  • Design Therapeutics' 5-year Cash from Investing Activities high stood at $23.0 million for Q1 2021, and its period low was -$50.1 million during Q4 2021.